Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Januvia. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel activation-condensation route for Sitagliptin intermediates. High yield, industrial scalability, cost-effective alternative to HOBt/EDC methods.
Novel synthetic route for Sitagliptin avoiding expensive catalysts. High yield, scalable process for pharmaceutical intermediates. Cost-effective manufacturing solution.
Novel low-cost route for Sitagliptin intermediates via chiral resolution. Reduces catalyst costs and simplifies scale-up for API manufacturing.